dose table scope
ONTRALFY: individual dose and frequency are separate titration choices
The renal/geriatric discussion favors adjusting individual doses rather than increasing frequency; it does not specify a reduction percentage.
What to reconcileKeep formulation and geriatric context attached, and avoid inventing a percentage reduction.
1 source identities and dates
GlobalRPh RX List - ONTRALFYGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Tizanidine - ONTRALFY oral solution; selected source sections only, not a complete prescribing monograph.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v4.9.
boundary units
EPRONTIA: indexed CrCl and individualized dialysis supplementation
The source uses indexed CrCl, not interchangeable indexed eGFR. It states that a dialysis supplement may be needed without providing a universal dose.
What to reconcilePreserve the renal measure and dialysis-system assumptions. Do not generate a fixed replacement amount.
1 source identities and dates
GlobalRPh RX List - EPRONTIAGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
EPRONTIA 25 mg/mL oral solution; selected adult renal guidance, not a complete indication-specific titration regimen.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v4.5.
route and indication
HYCAMTIN capsules and IV injection have different renal schedules
The selected IV renal table is single-agent guidance. The oral label uses different starting amounts and renal bands for its relapsed-SCLC indication. Both specify ideal body weight for Cockcroft-Gault.
What to reconcileConfirm route and indication before selecting a band. Oral and IV doses cannot be interchanged mg for mg, and the IV single-agent table is not the cervical-cancer combination schedule.
1 source identities and dates
GlobalRPh RX List - HYCAMTIN IVGlobalRPh-hosted RX List | Source revision: September 2018
Adults; single-agent IV HYCAMTIN; not oral capsules or cisplatin combination dosing
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v3.8.
source scope and renal guidance
Before use: Torsemide - DEMADEX oral tablets
Reduced tubular delivery may reduce diuretic response; renal disease does not imply a simple proportional dose reduction.
What to reconcileConfirm the exact product, indication, renal measure and full source before prescribing.
1 source identities and dates
GlobalRPh RX List - DEMADEX oral tabletsGlobalRPh-hosted RX List | Source revision: Revision not established in selected retrieval
Adult edema associated with chronic renal failure; immediate-release oral product.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v6.3.
boundary route and indication
IV-only administration and an overlapping printed boundary
The official renal table repeats an exact creatinine value in adjacent rows. Its doses are scoped to the hemophilia/tooth-extraction indication.
What to reconcileDo not silently select a row at that boundary, transfer an oral table, or extrapolate to another indication.
2 source identities and dates
GlobalRPh RX List - CYKLOKAPRONGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
CYKLOKAPRON intravenous injection for short-term hemorrhage prevention/reduction with tooth extraction in hemophilia; not an obstetric, trauma or oral menstrual-bleeding protocol.
Read this stored source Pfizer Medical / CYKLOKAPRON prescribing informationPfizer Medical / product prescribing information | Source revision: 8/2025
CYKLOKAPRON intravenous injection for short-term hemorrhage prevention/reduction with tooth extraction in hemophilia; not an obstetric, trauma or oral menstrual-bleeding protocol.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.4.
route indication duration
The oral renal table remains a limited menstrual course
The oral renal bands and treatment duration belong to the menstrual-bleeding product, not the IV indication.
What to reconcileKeep amount, frequency, course length and contraindications together.
1 source identities and dates
GlobalRPh RX List - LYSTEDAGlobalRPh-hosted RX List | Source revision: 12/2020
LYSTEDA 650 mg oral tablets for cyclic heavy menstrual bleeding in females of reproductive potential; not an IV tranexamic-acid regimen.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.4.
formulation scope
ORENITRAM: oral no-adjustment is not a cross-route conversion
A small oral dialysis PK study does not replace product-specific titration or transition guidance.
What to reconcileDo not apply the oral findings to an infused or inhaled schedule.
1 source identities and dates
GlobalRPh RX List - ORENITRAMGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Treprostinil - ORENITRAM extended-release tablets; selected source sections only, not a complete prescribing monograph.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v4.9.
combination product scope
HCTZ-alone monitoring does not bypass the combination restriction
DYAZIDE adds a potassium-sparing component and a qualitative renal-insufficiency restriction. The single-agent HCTZ extracts do not supply an exception for this combination.
What to reconcileReview potassium, renal trend and exact combination before treatment. Do not invent a cutoff or substitute a single-component renal statement.
1 source identities and dates
GlobalRPh RX List - DYAZIDEGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Oral fixed-dose triamterene/hydrochlorothiazide capsules
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v3.8.
evidence limit
EGATEN: not studied is not no adjustment required
The selected renal subsection supplies an absence-of-study statement, not a tested renal dose or dialysis pathway.
What to reconcileDo not use this record as an affirmative renal safety clearance; seek applicable product/specialist guidance.
1 source identities and dates
GlobalRPh RX List - EGATENGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
EGATEN oral product; selected evidence-gap statement only. No renal regimen is established here.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v4.5.
label version
Severe-impairment schedule added in newer labeling
The imported RX version lacks severe-impairment guidance that the selected DailyMed label now provides.
What to reconcileUse the official severe-impairment section and its BSA tablet table; do not apply the usual regimen or manufacture rounded tablet doses.
2 source identities and dates
LONSURF - trifluridine/tipiracil tabletsDailyMed / NLM; manufacturer prescribing information | Source revision: DailyMed page updated November 5, 2025; this is not asserted to be the prescribing-text revision date.
Adult oral LONSURF; doses expressed as the trifluridine component.
Read this stored source GlobalRPh RX List - LonsurfGlobalRPh-hosted RX List | Source revision: Revision date not established in selected retrieval.
Oral fixed combination; older RX List source version. Compare newer official-label guidance separately.
Read this stored source Source difference identified; final patient-specific adjudication required. Added: vearlier.
dose table scope
LONSURF: renal minimum and unequal AM/PM table cells must remain explicit
The severe-impairment pathway has its own reduction floor. A published table band uses unequal morning and evening tablet doses.
What to reconcileUse the exact BSA row and tablet instructions; do not split the daily total into unavailable or unsupported equal doses.
1 source identities and dates
GlobalRPh RX List - LONSURFGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Trifluridine / tipiracil - LONSURF; selected renal source sections only, not a complete prescribing monograph.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v4.7.
incomplete schedule and measure
Lengthening an interval is not a specified new interval
The selected source calls for less frequent administration but does not provide the reduced interval; the printed renal measure is indexed CrCl.
What to reconcileDo not supply a fixed interval or silently convert the units. Verify the exact current product.
1 source identities and dates
GlobalRPh RX List - TIGAN capsulesGlobalRPh-hosted RX List | Source revision: 3/2017
TIGAN 300 mg oral capsules in adults; not the separate injectable product.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.4.
source scope and renal guidance
A half-regimen instruction is not a tablet rule
The oral mirror expresses renal adjustment as a proportion of the indication-specific regimen. Renal impairment also increases potassium-monitoring relevance.
What to reconcileReview indication, trimethoprim amount, potassium and interactions. Do not generate an IV or Pneumocystis regimen from this fraction alone.
1 source identities and dates
GlobalRPh RX List - BACTRIMGlobalRPh-hosted RX List | Source revision: Revision not established in selected retrieval
BACTRIM / BACTRIM DS oral-product renal table and precautions.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v6.1.
renal measure and formulation
Adult and pediatric eGFR units differ within this label
The same printed numeric bands use absolute units in adults and indexed units in children. Packet restrictions also matter for reduced amounts.
What to reconcileDo not substitute one unit convention or use partial powder packets.
2 source identities and dates
GlobalRPh RX List - DAYBUEGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Trofinetide DAYBUE 200 mg/mL oral solution and DAYBUE STIX oral powder for Rett syndrome in patients aged 2 years and older. The selected dosing table begins at 9 kg.
Read this stored source DailyMed / DAYBUE and DAYBUE STIX exact labelDailyMed / Acadia Pharmaceuticals Inc. | Source revision: 3/2026
Trofinetide DAYBUE 200 mg/mL oral solution and DAYBUE STIX oral powder for Rett syndrome in patients aged 2 years and older. The selected dosing table begins at 9 kg.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.4.
qualitative precaution
Urine-output restrictions are not a CrCl calculator
The source uses qualitative renal exclusions and electrolyte precautions rather than a numerical renal adjustment table.
What to reconcileKeep the restrictions and monitoring visible; do not convert qualitative terms into an invented cutoff.
1 source identities and dates
GlobalRPh RX List - THAMGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
THAM tromethamine injection for acid-base correction; not a general renal-dose reduction algorithm.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.4.
scope and applicability
An IR renal schedule is not approval to use an XR capsule
The immediate-release source supplies a severe-renal instruction but leaves a separate PK evidence gap in other renal ranges.
What to reconcileRetain formulation and the source limitations; do not infer an intermediate regimen.
1 source identities and dates
GlobalRPh RX List - SANCTURA IRGlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Immediate-release trospium 20 mg tablets. Supplements the preserved GlobalRPh general statement; does not change its original text.
Read this stored source Source-specific interpretation; independent clinician adjudication pending. Added: v5.3.